4.6 Editorial Material

Cannabis for Medical Use: Clinical Pharmacology Perspectives on Scientific and Regulatory Challenges

Journal

CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 111, Issue 4, Pages 732-735

Publisher

WILEY
DOI: 10.1002/cpt.2470

Keywords

-

Funding

  1. National Institutes of Health National Center for Complementary and Integrative Health and Office of Dietary Supplements [U54 AT008909]

Ask authors/readers for more resources

The FDA has not approved cannabis as a safe and effective drug, but with the increasing state legalization of medical cannabis, healthcare providers and consumers should understand the safety and efficacy associated with cannabis.
There has been growing interest in developing therapeutic agents and other consumer products derived from cannabis and its components. To date, the US Food and Drug Administration (FDA) has not approved cannabis as a safe and effective drug for any indication. With the progressive state legalization of cannabis for medical use, healthcare providers and consumers must understand what is known about the safety and efficacy linked to cannabis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available